Breaking News, Financial News

Catalent 1Q

Catalent Pharma Solutions

1Q Revenues: $438 million (+10%)

1Q Loss: $11.3 million ($1.1 million in 1Q06 earnings)

Comments: Oral Technologies net revenue grew 9% to $235 million, while Sterile Technologies was up 26% to $71 million, fueled by higher utilization and throughput, along with new facilities in Brussels and North Carolina. The weakened U.S. dollar accounted for approximately 5% of sales growth.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters